CHC Healthcare Group · TWSE:4164
CHC Healthcare — 2018 Institutional Investor Conference
34 slides from CHC Healthcare's conference presentation, Dec 13, 2018
Slide 1: 2018 Institutional Investor Conference
2018 Institutional Investor Conference 4164 TT December 13, 2018
Slide 2: Disclaimer
Disclaimer • The information contained in this confidential document ("Presentation") has been prepared by CHC Healthcare Group (the "Company"). It has not been fully verified and is subject to material updating, revision and further amendment. • While the information contained herein has been prepa
Slide 3: Company Overview, Operational Results, Future Guidance, Q&A
Company Operational Future Q&A Overview Results Guidance 3
Slide 4: Company Overview
Company Operational Future Q&A Overview Results Guidance 4
Slide 5: Company Introduction
Company Introduction • Name： CHC Healthcare Group (4164 TT) • Date of Establish： 2009/11/27 (First subsidiary, Chiu Ho Instruments & Reagent, was founded in 1977) • President： Mr. Pei-Lin, Lee • Headquarters： Taipei • Branches： Taichung, Kaohsiung, Beijing, Guangzhou & Jakarta • Major Business： Prov
Slide 6: Company Milestones
Company Milestones Achieved ISO 9001 Certification 1977 Founded Chiu Ho Instruments & Reagent Co., Ltd 2018 Achieved OHSAS 18001 Certification Held “2017 International Elderly Care Industry Leaders 2017 Forum” 1985 Introduced radiotherapy equipment IBA first official revenue sharing contract signed
Slide 7: Members of BoD & Functional Committees
Members of BoD & Functional Committees Director Independent Directors Pei-Lin, Lee Audit Committee President / Representative of a Juristic Person Director Compensation Committee Tien-Ying, Lee Gui-Duan, Chen Independent Director Vice President CPA, EnWise CPAs & Co. Chun-Shung, Huang Chang-Jian, Ho
Slide 8: Solid Partnership with Top Global Brands
Solid Partnership with Top Global Brands Radiation Oncology Medical Imaging Ophthalmology Neuroscience 8
Slide 9: Full Service Solution Provider “TurnKey Solutions”
Full Service Solution Provider “TurnKey Solutions” Direct Selling Manufacturer CHC Revenue Sharing Partnership Hospital & Clinic Technical Services Site Planning Radiation Oncology Site Construction Neuroscience Operational Consulting Medical Imaging Installation Surgery Education & Training Mainten
Slide 10: Professional Team
Professional Team Yee-Min, Jen Chief Executive Officer Oncology Business Group (Director, Dept. of Radiation Oncology, Tri-Service General Hospital) Ming-Ta, Wen Dr. Chia-Ming, Wu Physician Oncology Business Group Oncology Business Group (Supervisor, Dept. of Radiation Oncology, Mennonite Christian
Slide 11: Operational Results
Company Operational Future Q&A Overview Results Guidance 11
Slide 12: Product Mix
Product Mix Service revenue Service 10% revenue 14% Sales revenue Sales revenue 35% 46% Revenue Revenue Sharing Sharing 44% 51% 2017 Q1-Q3 Value-Added Business Model 2018 Q1-Q3 12
Slide 13: Annual Results
Annual Results 2,000,000 2017 Q1-Q3 2018 Q1-Q3 1,800,000 1,600,000 Operating Revenue 1,498,994 1,844,845 Gross Profit 491,060 572,320 1,400,000 Gross Margin(%) 32.76% 31.02% (NT$ thousand) 1,200,000 Net Operating Income 232,816 357,949 1,000,000 2017 Q1~Q3 OP Margin (%) 15.53% 19.40% 800,000 2018 Q1
Slide 14: Monthly Operating Results
Monthly Operating Results 2,400,000 2,200,000 2,000,000 1,800,000 (NT$ thousand) 1,600,000 1,400,000 1,200,000 2017 1,000,000 2018 800,000 600,000 400,000 200,000 0 Jan Feb Mar Apr May Jun Jul Aug Sep Oct Nov Dec YTD 2017 2018 YoY 2017 2018 YoY Jan 110,226 141,057 27.97% Jul 145,050 192,946 33.02% F
Slide 15: Future Guidance
Company Operational Future Q&A Overview Results Guidance 15
Slide 16: Future Guidance
Future Guidance • Introduce High-Tech Product & Precise Medicine • Medical Management Service Output to Overseas • Enter Elderly Care Market with New Perspective 16
Slide 17: High-Tech Product & Precise Medicine
High-Tech Product & Precise Medicine 30+ 50+ 65%+ YEARS OF EXPERIENCE CENTERS IN OPERATION / DEVELOPMENT PATIENTS TREATED BY IBA 17
Slide 18: High-Tech Product & Precise Medicine
High-Tech Product & Precise Medicine Nowadays A Growing Treatment Option (patients treated per year) 160,000 500,000 patients have already been 400,000 300,000 treated with proton therapy 300,000 200,000 100,000+ 100,000 16,200 patients have chosen IBA proton therapy system - 2015 2030 Source: IBA 2
Slide 19: High-Tech Product & Precise Medicine
High-Tech Product & Precise Medicine Think Big, Scale Smart S2C2: next generation cyclotron design Only compact solution with IMPT Equip with Pencil Beam Scanning Efficient workflow and operations 19 ProteusONE
Slide 20: Elekta's MR-Linac – Two worlds, one future
High-Tech Product & Precise Medicine Elekta's MR-Linac – Two worlds, one future 20
Slide 21: High-Tech Product & Precise Medicine
High-Tech Product & Precise Medicine Unity 21
Slide 22: High-Tech Product & Precise Medicine
High-Tech Product & Precise Medicine CT MR Prostate? Prostate! 22
Slide 23: High-Tech Product & Precise Medicine
High-Tech Product & Precise Medicine 23
Slide 24: High-Tech Product & Precise Medicine
High-Tech Product & Precise Medicine 24
Slide 25: NUCLeUS smart digital operating room platform
High-Tech Product & Precise Medicine NUCLeUS The smart digital operating room platform 25
Slide 26: Medical Management Service Output to Overseas
Medical Management Service Output to Overseas Operation Division Consulting Management Hospital Management Equipment Provider 26
Slide 27: Present Revenue Sharing Partnership
Medical Management Service Output to Overseas < Present Revenue Sharing Partnership > Taiwan China Indonesia 27
Slide 28: Medical Management Service Output to Overseas
Medical Management Service Output to Overseas 28
Slide 29: Medical Management Service Output to Overseas
Medical Management Service Output to Overseas 29
Slide 30: Enter Elderly Care Market with New Perspective
Enter Elderly Care Market with New Perspective 30
Slide 31: Enter Elderly Care Market with New Perspective
Enter Elderly Care Market with New Perspective Year when ageing status changed Speed of population ageing (Year) Ageing Society Aged Society Super-Aged society 7% to 14% 14% to 20% (7%) (14%) (20%) Taiwan 1993 2018 2026(e) 25 8(e) Japan 1970 1994 2005 24 11 South Korea 1999 2017 2026(e) 18 9(e) Sing
Slide 32: Enter Elderly Care Market with New Perspective
Enter Elderly Care Market with New Perspective 2016/10 MoU Signed 2018/09 JV Company Established 32
Slide 33: Company Overview, Results, Guidance, Q&A
Company Operational Future Overview Results Guidance Q&A 33
Slide 34: Thank you
Thank you 34
CHC Healthcare Group — 2018 Institutional Investor Conference on 6ix